Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristian Rodriguez

Showing results (91-100 of 149) with videos related to

Pageof 15
Sort By:
Journal of the American Chemical Society|May 14, 2021
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor ActivityPaola Amero, Ganesh L R Lokesh, Rajan R Chaudhari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2015
Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian CancerVianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, et al.
Cell Reports|November 3, 2021
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start siteJasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian CancerYu Kang, Archana S Nagaraja, Guillermo N Armaiz-Pena, et al.
Molecular Therapy. Nucleic Acids|January 18, 2019
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven CancersHamada A Mokhlis, Recep Bayraktar, Nashwa N Kabil, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector deliveryHaifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Pageof 15

Showing results (91-100 of 149) with videos related to

Sort By:
Pageof 15
Journal of the American Chemical Society|May 14, 2021
Conversion of RNA Aptamer into Modified DNA Aptamers Provides for Prolonged Stability and Enhanced Antitumor ActivityPaola Amero, Ganesh L R Lokesh, Rajan R Chaudhari, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2015
Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian CancerVianey Gonzalez-Villasana, Enrique Fuentes-Mattei, Cristina Ivan, et al.
Cell Reports|November 3, 2021
RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start siteJasmine George, Yongsheng Li, Ishaque P Kadamberi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 20, 2015
Adrenergic Stimulation of DUSP1 Impairs Chemotherapy Response in Ovarian CancerYu Kang, Archana S Nagaraja, Guillermo N Armaiz-Pena, et al.
Molecular Therapy. Nucleic Acids|January 18, 2019
The Modulatory Role of MicroRNA-873 in the Progression of KRAS-Driven CancersHamada A Mokhlis, Recep Bayraktar, Nashwa N Kabil, et al.
Ebiomedicine|November 30, 2018
Exosomal miRNA confers chemo resistance via targeting Cav1/p-gp/M2-type macrophage axis in ovarian cancerPinar Kanlikilicer, Recep Bayraktar, Merve Denizli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2013
Enhancing chemotherapy response with sustained EphA2 silencing using multistage vector deliveryHaifa Shen, Cristian Rodriguez-Aguayo, Rong Xu, et al.
Oncotarget|April 21, 2017
Targeting the centriolar replication factor STIL synergizes with DNA damaging agents for treatment of ovarian cancerNoa Rabinowicz, Lingegowda S Mangala, Kevin R Brown, et al.
Cancer Cell|June 15, 2016
ΔNp63/DGCR8-Dependent MicroRNAs Mediate Therapeutic Efficacy of HDAC Inhibitors in CancerMarco Napoli, Avinashnarayan Venkatanarayan, Payal Raulji, et al.
Molecular Cancer Therapeutics|November 14, 2018
Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4Alejandro Villar-Prados, Sherry Y Wu, Karem A Court, et al.
Pageof 15